Enzon Pharmaceuticals, Inc. (ENZN)

Enzon Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Net Income	1.37	-0.19	-0.47	-1.31	-0.98
Other Operating Activities	-0.07	-0.47	-0.03	0.93	7.88
Operating Cash Flow	1.31	-0.66	-0.5	-0.38	6.91
Dividends Paid	-1.28	0	0	0	-7.96
Common Stock Issued	0	0	0	43.6	0
Other Financing Activities	-	-1.28	-2.02	-0.52	-
Financing Cash Flow	-1.28	-1.28	-2.02	43.08	-7.96
Net Cash Flow	0.03	-0.66	-0.5	42.7	-1.05
Free Cash Flow	1.31	-0.66	-0.5	-0.38	6.91
Free Cash Flow Margin	-	-2534.62%	-71.47%	-730.77%	3335.75%
Free Cash Flow Per Share	0.02	-0.01	-0.01	-0.01	0.16

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.